Supported by The Macula Foundation Inc., New York, New York, USA. D.C. was supported in part by a studentship from Fundação Luso-Americana para o Desenvolvimento (FLAD, USA R&D@PhD – Proj 2020/0140). P.R. was supported by The Philippe Foundation.
Disclosure: D. Cabral, None; P. Ramtohul, None; L. Zatreanu, None; D. Galhoz, None; M. Leitao, None; V. Noguerira, None; D. Sarraf, Amgen (California, USA) (C, F), Boehringer (F), Genentech (San Francisco, California) (C, 400F), Heidelberg (Heidelberg, Germany); (F), Iveric Bio (C), Novartis (Basel, Switzerland) (C, F), Optovue (California, USA) (C, F), Regeneron (NY, USA) (F), Bayer (Berlin, Germany) (C, F), Topcon (Tokyo, Japan) (F); K.B. Freund, Genentech (San Francisco, California) (C), Optovue (California, USA) (C), Zeiss (Dublin, USA) (C), Heidelberg Engineering (Heidelberg, Germany) (C), Allergan Inc. (Irvine, California, USA) (C), Bayer (Berlin, Germany) (C), Novartis (Basel, Switzerland) (C), Genentech (San Francisco, California) (F), Roche (Basel, Switzerland) (F)